Yesterday, Salix Pharmaecuticals accepted Valeant’s raised takeover offer of $10.96 billion in cash, ending the bidding war between Endo and Valeant for the gastrointestinal drug maker. Valeant’s new offer of $173 per share is about a 10% increase over its original offer of $158 per share. Valeant also paid $296 million for assets of bankrupt …
NY Times – DealB%k
- Sign Up for DealBook November 21, 2024Make sense of the latest business and policy headlines with our daily newsletter.
- Dissecting the DOGE Playbook November 21, 2024Elon Musk and Vivek Ramaswamy have unveiled their first plans to trim government spending, a blueprint that mirrors how the tech mogul cut costs at Twitter.
- Hennessy Workers Strike Over Plans to Bottle Cognac in China November 21, 2024The walkout in France is the latest development in a simmering trade war between Europe and China.